ARCHIVES

FDA Approves BMS’s Yervoy For Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

February 14, 2014

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991